| AOR | adjusted odds ratio |
| BIFAP | base de datos para la investigación farmacoepidemiológica en atención primaria |
| BMI | body mass index |
| CI | confidence interval |
| COX | cyclooxygenase |
| CRC | colorectal cancer |
| CV | cardiovascular |
| CVD | cardiovascular disease |
| ES | effect size |
| GI | gastrointestinal |
| H2 | type-2 histamine receptor |
| HMG-CoA | 3-hydroxy-3-methylglutaryl-coenzyme A |
| ICPC | international classification in primary care |
| ICD | international classification of diseases |
| IQR | interquartile range |
| LDL | low-density lipoproteins |
| MICE | multiple imputation by chained equations |
| NSAID | nonsteroidal anti-inflammatory drugs |
| OR | odds ratio |
| PCP | primary care physician |
| PGE2 | prostaglandin-E2 |
| PPAR | peroxisome proliferator-activated receptor |
| PRISMA | preferred reporting items for systematic reviews and meta-analysis |
| PPI | proton-pump inhibitors |
| SD | standard deviation |
| SYSADOA | symptomatic slow-acting drugs for osteoarthritis |
| USPSTF | United States Preventive Services Task Force |